Maria Aparecida Barbato Frazao Vital
Overview
Explore the profile of Maria Aparecida Barbato Frazao Vital including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lacerda G, Oliviera P, Vital M, Slomp Junior H, Galduroz J, Andreatini R
Acta Neuropsychiatr
. 2024 Oct;
36(4):189-194.
PMID: 39357069
There is a substantial use of Complementary and Alternative Medicine (CAM) among both the general population and psychiatric patients, with only a minority of these users disclosing this information to...
2.
da Silva E, Fischer J, Souza I, Andrade A, Souza L, Andrade M, et al.
Int J Mol Sci
. 2024 Mar;
25(5).
PMID: 38474019
Alzheimer's Disease (AD) is an age-related neurodegenerative disorder characterized by progressive memory loss and cognitive impairment, affecting 35 million individuals worldwide. Intracerebroventricular (ICV) injection of low to moderate doses of...
3.
Galduroz J, Zampronio A, Vital M, Sallet P, Zohar J, Andreatini R
Trends Psychiatry Psychother
. 2024 Jan;
PMID: 38240314
Neuroscience-Based Nomenclature (NbN) is a proposal to provide a nomenclature based on neuroscience and pharmacology instead of the old disease-based classification. NbN is based on the mechanism of action and...
4.
Vecchia D, Kanazawa L, Wendler E, Hocayen P, Vital M, Takahashi R, et al.
Brain Res Bull
. 2020 Dec;
168:63-73.
PMID: 33359641
The most common features of Parkinson's disease (PD) are motor impairments, but many patients also present depression and memory impairment. Ketamine, an N-methyl-d-aspartate (NMDA) receptor antagonist, has been shown to...
5.
Machado M, Bassani T, Coppola-Segovia V, Moura E, Zanata S, Andreatini R, et al.
Pharmacol Rep
. 2019 May;
71(4):556-564.
PMID: 31132685
Background: Peroxisome proliferator-activated receptor γ (PPAR-γ) agonists have received much attention in research because of their neuroprotective and anti-inflammatory effects that reduce cell death and halt the progression of neurodegeneration....
6.
Vecchia D, Kanazawa L, Wendler E, Hocayen P, Bruginski E, Campos F, et al.
Behav Brain Res
. 2018 Jan;
342:1-10.
PMID: 29307665
Parkinson's disease is a chronic neurodegenerative disorder characterized by cardinal motor features, such as bradykinesia, but also vocal deficits (e.g. difficulties to articulate words and to keep the tone of...
7.
Bonato J, Bassani T, Milani H, Vital M, de Oliveira R
Exp Neurol
. 2017 Nov;
300:188-200.
PMID: 29162435
Deficiencies in adult hippocampal neurogenesis have been suggested to be a possible pathophysiological mechanism that underlies depressive symptoms that are often observed in patients with Parkinson's disease (PD). Pioglitazone, a...
8.
Siba I, Bortolanza M, Vital M, Andreatini R, Cunha J, Del Bel E, et al.
Behav Brain Res
. 2017 Mar;
326:173-186.
PMID: 28284945
There is an urgent need to understand the pathophysiological mechanisms related to anxiety associated with diabetes, seeking more effective alternative treatments to treat it. For that, the effect of a...
9.
Capitelli C, Lopes C, Alves A, Barbiero J, Oliveira L, da Silva V, et al.
Int J Med Sci
. 2014 Aug;
11(10):1049-64.
PMID: 25136260
The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) animal model is a useful tool to study Parkinson's disease (PD) and was used in the present study to investigate the potential beneficial as well as deleterious...
10.
da Cunha C, Wietzikoski E, Bortolanza M, Dombrowski P, dos Santos L, Boschen S, et al.
J Neural Transm Suppl
. 2010 Apr;
(73):147-60.
PMID: 20411775
The roles of the nigrostriatal pathway are far beyond the simple control of motor functions. The tonic release of dopamine in the dorsal and ventral striatum controls the choice of...